Tuberculosis relapse in vietnam is significantly associated with mycobacterium tuberculosis beijing genotype infections

Journal of Infectious Diseases

Volumn 207, Issue 10, 2013, Pages 1516-1524

  Huyen, Mai N T ^a   Buu, Tran N ^a   Tiemersma, Edine ^b,e   Lan, Nguyen T N ^a   Dung, Nguyen H ^a   Kremer, Kristin ^c   Soolingen, Dick V ^c,d   Cobelens, Frank G J ^e,f  

^a Pham Ngoc Thach Hospital   (Viet Nam)

^b KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Beijing genotype; recurrence; relapse; treatment; tuberculosis; Vietnam

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; VARIABLE NUMBER OF TANDEM REPEAT; VIET NAM;

ADULT; AGED; ANTITUBERCULAR AGENTS; COHORT STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NIACIN; PREVALENCE; PROSPECTIVE STUDIES; RECURRENCE; RIFAMPIN; RURAL POPULATION; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; VIETNAM;

EID: 84876521556     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit048     Document Type: Article

References (38)

1. World Health Organization. Who report 2011 global tuberculosis control. Geneva: World Health Organization, 2011.
2. Brudey K, Driscoll JR, Rigouts L, et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BioMed Central Microbiology 2006; 6:23.
3. Anh DD, Borgdorff MW, Van LN, et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerging Infectious Diseases 2000; 6:302-5. (Pubitemid 30396388)
4. Hanekom M, Gey van Pittius NC, McEvoy C, Victor TC, Van Helden PDWarren RM. Mycobacterium tuberculosis Beijing genotype: a template for success. Tuberculosis (Edinb) 2011; 91:510-23.
5. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerging Infectious Diseases 2006; 12:736-43.
6. Filliol I, Driscoll JR, Van Soolingen D, et al. Global distribution of Mycobacterium tuberculosis spoligotypes. Emerging Infectious Diseases 2002; 8:1347-9. (Pubitemid 35334712)
7. Bifani PJ, Plikaytis BB, Kapur V, et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA : The Journal of the American Medical Association 1996; 275:452-7. (Pubitemid 26065618)
8. Toungoussova OS, Sandven P, Mariandyshev AO, Nizovtseva NI, Bjune G, Caugant DA. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. Journal of Clinical Microbiology 2002; 40:1930-7. (Pubitemid 34596365)
9. Drobniewski F, Balabanova Y, Nikolayevsky V, et al. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA : The Journal of the American Medical Association 2005; 293:2726-31. (Pubitemid 40965084)
10. Buu TN, Huyen MN, Lan NT, et al. The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural Vietnam. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union Against Tuberculosis and Lung Disease 2009; 13:900-6.
11. Johnson R, Warren RM, van der Spuy GD, et al. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union against Tuberculosis and Lung Disease 2010; 14:119-21.
12. Parwati I, Alisjahbana B, Apriani L, et al. Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia. The Journal of Infectious Diseases 2010; 201:553-7.
13. Feng JY, Su WJ, Tsai CC, Chang SC. Clinical impact of Mycobacterium tuberculosis W-Beijing genotype strain infection on aged patients in Taiwan. Journal of Clinical Microbiology 2008; 46: 3127-9.
14. Burman WJ, Bliven EE, Cowan L, et al. Relapse associated with active disease caused by Beijing strain of Mycobacterium tuberculosis. Emerging Infectious Diseases 2009; 15:1061-7.
15. Nahid P, Bliven EE, Kim EY, et al. Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS One 2010; 5:e10753.
16. Buu TN, Huyen MN, van Soolingen D, et al. The Mycobacterium tuberculosis Beijing genotype does not affect tuberculosis treatment failure in Vietnam. Clinical Infectious Diseases 2010; 51:879-86.
17. Lan NT, Lien HT, Tung le B, Borgdorff MW, Kremer K, van Soolingen D. Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerging Infectious Diseases 2003; 9:1633-5. (Pubitemid 37505466)
18. Sun YJ, Lee AS, Wong SY, Paton NI. Association of Mycobacterium tuberculosis Beijing genotype with tuberculosis relapse in Singapore. Epidemiology and Infection 2006; 134:329-32. (Pubitemid 43280242)
19. Jindani A, Nunn AJ, Enarson DA. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Lancet 2004; 364: 1244-51. (Pubitemid 39311345)
20. International Union Against Tuberculosis and Lung Disease. Technical guide-sputum examination for tuberculosis direct microscopy in low-income countries. 5th ed. Paris: The Union, 2000.
21. World Health Organization. Guideline for surveillance of drug resistance in tuberculosis. 2nd ed. Geneva: World Health Organization, 2003.
22. van Soolingen D, de Haas PEW, Kremer K. Restriction fragment length polymorphism typing of mycobacteria. In: Parish T, Stoker NG, eds. Mycobacterium tuberculosis protocols. Totowa, NJ: Humana Press, 2001:165-203.
23. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. Journal of Clinical Microbiology 1997; 35:907-14. (Pubitemid 27146535)
24. Supply P, Allix C, Lesjean S, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. Journal of Clinical Microbiology 2006; 44:4498-510. (Pubitemid 44937085)
25. Kremer K, Glynn JR, Lillebaek T, et al. Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. Journal of Clinical Microbiology 2004; 42:4040-9. (Pubitemid 39296121)
26. de Jong BC, Hill PC, Aiken A, et al. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. The Journal of Infectious Diseases 2008; 198:1037-43.
27. Dormans J, Burger M, Aguilar D, et al. Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clinical and Experimental Immunology 2004; 137:460-8. (Pubitemid 39128071)
28. Lopez B, Aguilar D, Orozco H, et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clinical and Experimental Immunology 2003; 133:30-7. (Pubitemid 36791939)
29. Wu S, Barnes PF, Samten B, et al. Activation of the eis gene in a WBeijing strain of Mycobacterium tuberculosis correlates with increased SigA levels and enhanced intracellular growth. Microbiology 2009; 155:1272-81.
30. Ferro BE, Nieto LM, Rozo JC, Forero L, van Soolingen D. Multidrugresistant Mycobacterium tuberculosis, Southwestern Colombia. Emerging Infectious Diseases 2011; 17:1259-62.
31. Makinen J, Marjamaki M, Haanpera-Heikkinen M, et al. Extremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: a population-based study. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 2011; 30:1119-26.
32. de Steenwinkel JE, Ten Kate MT, de Knegt GJ, et al. Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB. Emerging Infectious Diseases 2012; 18:660-3.
33. UNAIDS. Viet Nam. HIV and AIDS estimates. 2011. http://www. unaids.org/en/regionscountries/countries/vietnam/. Accessed 4 October 2012.
34. Crampin AC, Mwaungulu JN, Mwaungulu FD, et al. Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS 2010; 24:417-26.
35. van Rie A, Warren RM, Beyers N, et al. Transmission of a multidrugresistant Mycobacterium tuberculosis strain resembling "strainW"among noninstitutionalized, human immunodeficiency virus-seronegative patients. The Journal of Infectious Diseases 1999; 180:1608-15. (Pubitemid 29506465)
36. Feng JY, Su WJ, Liu LY, Tsai CC, Chang SC. Radiological presentation of pulmonary tuberculosis infected by the W-Beijing Mycobacterium tuberculosis strain. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union Against Tuberculosis and Lung Disease 2009; 13:1387-92.
37. Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union Against Tuberculosis and Lung Disease 2002; 6:858-64.
38. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. The International Journal of Tuberculosis and Lung Disease : The Official Journal of the International Union Against Tuberculosis and Lung Disease 1999; 3:S231-79.